Skip to content
Forcyte Biotechnologies, Inc

the function-first biology company

Menu
  • Company
    • VISION
    • ABOUT
    • TEAM
    • NEWS
    • CONTACT
  • Platform
    • FLECS TECHNOLOGY
    • PUBLICATIONS
  • Mechanomics
    • MECHANOMIC DISEASES
    • PIPELINE

Forcyte’s Cardiac Tissuoid assay is now available

Posted on May 7, 2019May 7, 2019 by forcyte
Posted in Uncategorized

Recent Posts

  • Forcyte Bio Secures New Funding From Y Combinator & Others, Bringing Total to >$5.7 Million
  • Forcyte awarded Phase 2 SBIR by NIH / NCATS to develop pseudo-3D contractile “tissuoid” assay enabling study of coordinated cell contractions and tachyphylaxis
  • New App Note covering FLECS Technology in collaboration with Molecular Devices is now available:
  • Forcyte’s Cardiac Tissuoid assay is now available
  • Forcyte Bio to participate in Innovation AveNEW for Startups Showcase at SLAS 2019

Recent Comments

    Archives

    • June 2022
    • September 2019
    • May 2019
    • January 2019
    • July 2018
    • April 2018
    • March 2018
    • November 2017

    Categories

    • Conferences
    • Funding
    • New Materials
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Copyright © 2017 Forcyte Biotechnologies, Inc